How much funding has Diadem Biotherapeutics raised?

Diadem Biotherapeutics has raised $250K in total funding, most recently a Seed round.

Who are Diadem Biotherapeutics's investors?

Diadem Biotherapeutics's investors include IndieBio.

When was Diadem Biotherapeutics founded?

Diadem Biotherapeutics was founded in 2019.

Where is Diadem Biotherapeutics headquartered?

Diadem Biotherapeutics is headquartered in Torrance, California, United States.

What industry is Diadem Biotherapeutics in?

Diadem Biotherapeutics operates in Biotech, Healthcare.

How many employees does Diadem Biotherapeutics have?

Diadem Biotherapeutics has 1-10 employees.

Diadem Biotherapeutics

Tuning immunity

Torrance, United States · Founded 2019 · $250K raised

Biotech

Healthcare

Headquarters: Torrance, California
Employees: 1–10
Founded: 2019
Business Model: B2B

Website: diadembio.com
Total Funding: $250K
Last Round: $250K SeedNov 2019
Rounds: 1

About

Diadem Biotherapeutics is a clinical-stage biotechnology company engineering first-in-class extracellular vesicles to treat cancer and autoimmune conditions. Its proprietary DECOSTAR™ platform uses decorated extracellular vesicles for costimulatory activation or repression of immune receptors, solving the biophysical challenges in agonist signaling and enabling access to validated immunotherapy targets. The company is focused on harnessing the untapped potential of immune cell receptor activation to develop novel biologics for chronic inflammatory diseases and oncology.

Summary

Diadem Biotherapeutics is a Biotech company based in Torrance, United States, founded in 2019. It has raised $250K in total across 1 round, most recently a $250K Seed round in Nov 2019. Investors include IndieBio.